Takahashi Masayo, Haruta Masatoshi
Department of Experimental Therapeutics, Translational Research Center, Kyoto University Hospital, Kyoto, Japan.
Methods Mol Biol. 2006;330:417-29. doi: 10.1385/1-59745-036-7:417.
For cell replacement therapies of retinal diseases, the most-needed cells are retinal pigment epithelial cells and photoreceptor cells; lens cells are needed for replacement of the cataract. Stromal cell-derived inducing activity induces the differentiation of mouse embryonic stem (ES) cells into neural cells, including midbrain tyrosine hydroxylase-positive dopaminergic neurons, and ocular cells; the method also works with primate ES cells. We describe the methods to induce retinal pigment epithelial and lens cells from monkey ES cells using stromal cell-derived inducing activity and show the characteristics of those cells in vitro and in vivo.
对于视网膜疾病的细胞替代疗法,最需要的细胞是视网膜色素上皮细胞和光感受器细胞;白内障替代则需要晶状体细胞。基质细胞衍生诱导活性可诱导小鼠胚胎干细胞分化为神经细胞,包括中脑酪氨酸羟化酶阳性多巴胺能神经元和眼细胞;该方法对灵长类胚胎干细胞也有效。我们描述了利用基质细胞衍生诱导活性从猴胚胎干细胞诱导生成视网膜色素上皮细胞和晶状体细胞的方法,并展示了这些细胞在体外和体内的特性。